AKEBIA THERAPEUTICS, INC. Other Current Assets
AKEBIA THERAPEUTICS, INC. (AKBA) had Other Current Assets of $5.77 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Other Assets, Current $5.77M.
- 2026-03-31: Other Assets, Current $3.60M.
- 2025-12-31: Other Assets, Current $3.77M.
- 2025-09-30: Other Assets, Current $5.33M.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $5.77M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $3.60M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $3.77M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $5.33M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $7.83M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $7.92M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.32M 10-K · filed 2026-02-26 |
| 2024-09-30 | $6.21M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $7.33M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $4.81M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.75M 10-K · filed 2025-03-13 |
| 2022-12-31 | $17.25M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |